4,502 reports of this reaction
10.4% of all ORLISTAT reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for ORLISTAT, manufactured by Haleon US Holdings LLC. There are 4,502 FDA adverse event reports linking ORLISTAT to DRUG INEFFECTIVE. This represents approximately 10.4% of all 43,367 adverse event reports for this drug.
Patients taking ORLISTAT who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is a frequently reported adverse event for ORLISTAT, accounting for a significant proportion of all reports.
In addition to drug ineffective, the following adverse reactions have been reported for ORLISTAT:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 4,502 FDA reports for ORLISTAT. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 10.4% of all adverse event reports for ORLISTAT, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking ORLISTAT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.